Pradžia › Širdies nepakankamumas › Wisconsin › Milwaukee
Širdies nepakankamumas klinikiniai tyrimai Milwaukee, WI
16 tyrimai dėl Širdies nepakankamumas ieško dalyvių vietose Milwaukee ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
ELEVATE-HFpEF Clinical Study
Renkami dalyviai
- Froedtert Hospital, Milwaukee
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Renkami dalyviai3 fazė
- ProHealth Care Research Institute and Cardiology Associates, Waukesha · už 17 mylių
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Renkami dalyviai3 fazė
- Medical College of Wisconsin / Froedtert Hospital, Milwaukee
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Renkami dalyviai3 fazė
- Advocate Aurora Saint Lukes Medical Center, Milwaukee
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Renkami dalyviai3 fazė
- Milwaukee, WI Investigative Site 10061, Milwaukee
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Renkami dalyviai
- Aurora St. Luke's Medical Center, Milwaukee
Peripheral Venous Pressure (PVP) Trial
Renkami dalyviai
- Aurora St. Luke's Medical Center, Milwaukee
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Renkami dalyviai2 fazė
- Froedtert Hospital - Center for Advanced Care, Milwaukee
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Renkami dalyviaiStebimasis tyrimas
- Milwaukee, Milwaukee
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Renkami dalyviaiStebimasis tyrimas
- Medical College of Wisconsin, Inc (PI Address), Milwaukee
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Renkami dalyviai3 fazė
- Aurora St. Luke's Medi Ctr, Milwaukee
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Renkami dalyviai3 fazė
- Milwaukee, WI Investigative Site FIN-10428, Milwaukee
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Renkami dalyviai
- Advocate Aurora St. Luke's, Milwaukee
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Renkami dalyviai
- Aurora Medical Group, Milwaukee
CCM OPEN HF Registry
Renkami dalyviaiStebimasis tyrimas
- Advocate Aurora Health-St. Lukes, Milwaukee
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Renkami dalyviai
- Advocate Aurora Research Institute, Milwaukee
Širdies nepakankamumas tyrimai kituose miestuose
- New York City, NY51 tyrimas
- Boston, MA44 tyrimai
- Dallas, TX42 tyrimai
- Houston, TX36 tyrimai
- Cleveland, OH33 tyrimai
- Chicago, IL31 tyrimas
- Philadelphia, PA31 tyrimas
- San Francisco, CA29 tyrimai
- St. Louis, MO26 tyrimai
- Durham, NC26 tyrimai
- Kansas City, MO25 tyrimai
- Atlanta, GA25 tyrimai
Kiti tyrimai Milwaukee
- Krūties vėžys23 tyrimai
- Nedidelinių ląstelių plaučių vėžys22 tyrimai
- Vėžys (visų tipų)22 tyrimai
- Plaučių vėžys21 tyrimas
- Kartotinė mieloma21 tyrimas
- Prostatos vėžys20 tyrimai
- Folikulinė limfoma19 tyrimai
- Kasos vėžys18 tyrimai
- Ne Hodžkino limfoma18 tyrimai
- Kiaušidžių vėžys17 tyrimai
- Ūmi mieloidinė leukemija17 tyrimai
- Berkito limfoma16 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.